Scientific Advisory Board and Founders
The scientific advisors and founders of Alnylam Pharmaceuticals are among the world's leaders in RNAi and in broad aspects of medical research.
The Alnylam Scientific Advisory Board and Advisors include:
Phillip Sharp, Ph.D., Institute Professor, The Koch Institute for Integrative Cancer Research, MIT; Former Director, McGovern Institute for Brain Research; Nobel Laureate; founder of Biogen, Inc. (now Biogen Idec, Inc.) and Alnylam; National Academy of Sciences
David Bartel, Ph.D., Member of the Whitehead Institute and Professor of Biology at MIT, Investigator of the Howard Hughes Medical Institute, noted RNA and RNAi expert, and a founder of Alnylam
Fritz Eckstein, Ph.D., Inventor of phosphorothioate modifications and Professor of Chemistry, Max Planck Institute for Experimental Medicine, and noted RNA and RNAi expert
Robert Langer, Ph.D., Germeshausen Professor at MIT and the only active member of all three U.S. National Academies — the National Academy of Sciences, the Institute of Medicine, and the National Academy of Engineering
Judy Lieberman, M.D., Ph.D., Senior Investigator at the Immune Disease Institute, and Professor of Pediatrics, at Harvard Medical School, and the Director of the Division of AIDS at Harvard Medical School
Stephen N. Oesterle, M.D., Senior Vice President for Medicine and Technology, Medtronic, Inc.
Paul Schimmel, Ph.D., Hahn Professor of Molecular Biology and Chemistry at Scripps Research Institute, National Academy of Sciences, American Academy of Arts and Sciences, and Institute of Medicine member, cofounder of Cubist, Alkermes and Repligen, and a founder and member of the Board of Directors of Alnylam
Markus Stoffel, M.D., Ph.D., Professor for Metabolic Diseases at the Institute of Molecular Systems Biology, Swiss Federal Institute of Technology (ETH) in Zurich
Thomas Tuschl, Ph.D., Professor at Rockefeller University, Investigator of the Howard Hughes Medical Institute, noted RNA and RNAi expert, and a founder of Alnylam
Phillip D. Zamore, Ph.D., Gretchen Stone Cook Professor of Biomedical Sciences at the University of Massachusetts Medical School, Investigator of the Howard Hughes Medical Institute, noted RNA and RNAi expert, and a founder of Alnylam
